Hefei Lifeon Pharmaceutical Co Ltd (003020) — Capital Reinvestment Ratio
Hefei Lifeon Pharmaceutical Co Ltd (003020) has a Capital Reinvestment Ratio of 0.04x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥667.63 Million) in capital expenditures (CN¥25.90 Million). Check 003020 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hefei Lifeon Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2025)
This chart tracks Hefei Lifeon Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 12 annual periods. For the full cash flow conversion analysis, see Hefei Lifeon Pharmaceutical Co Ltd (003020) cash flow conversion.
Annual Capital Reinvestment Ratio for Hefei Lifeon Pharmaceutical Co Ltd (2013–2025)
Year-by-year Capital Reinvestment Ratio for Hefei Lifeon Pharmaceutical Co Ltd from 2013 to 2025. See free cash flow generation of Hefei Lifeon Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.56x | CN¥212.89 Million | CN¥118.46 Million | ▼ -28.9% |
| 2024 | 0.78x | CN¥197.53 Million | CN¥154.49 Million | ▼ -19.4% |
| 2023 | 0.97x | CN¥203.67 Million | CN¥197.54 Million | ▼ -21.0% |
| 2022 | 1.23x | CN¥200.64 Million | CN¥246.43 Million | ▲ +4.3% |
| 2021 | 1.18x | CN¥158.70 Million | CN¥186.95 Million | ▲ +261.6% |
| 2020 | 0.33x | CN¥172.49 Million | CN¥56.20 Million | ▲ +10.8% |
| 2019 | 0.29x | CN¥149.30 Million | CN¥43.90 Million | ▼ -35.0% |
| 2018 | 0.45x | CN¥64.45 Million | CN¥29.16 Million | ▼ -55.3% |
| 2017 | 1.01x | CN¥11.32 Million | CN¥11.46 Million | ▲ +368.3% |
| 2016 | 0.22x | CN¥58.99 Million | CN¥12.74 Million | ▼ -41.5% |
| 2014 | 0.37x | CN¥92.05 Million | CN¥34.01 Million | ▼ -70.4% |
| 2013 | 1.25x | CN¥35.54 Million | CN¥44.43 Million | — |